Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,694 | -152,148 | -108,723 | -62,091 | -28,383 |
| Depreciation Amortization | -2,225 | -8,057 | -6,263 | -4,063 | -1,469 |
| Accounts payable and accrued liabilities | 1,597 | -3,453 | -6,516 | -6,454 | -5,909 |
| Other Working Capital | -9,438 | 2,660 | 3,388 | -2,475 | -8,619 |
| Other Operating Activity | 7,354 | 26,319 | 22,617 | 16,471 | 10,550 |
| Operating Cash Flow | $-54,406 | $-134,679 | $-95,497 | $-58,612 | $-33,830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -187 | -972 | -327 | -89 | N/A |
| Purchase Of Investment | -89,992 | -703,015 | -409,000 | -336,055 | -254,967 |
| Sale Of Investment | 106,246 | 278,958 | 205,681 | 94,181 | 35,681 |
| Other Investing Activity | -750 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $15,317 | $-425,029 | $-203,646 | $-241,963 | $-219,286 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,533 | 645,913 | 298,602 | 297,850 | 294,411 |
| Common Stock Repurchased | N/A | -13 | -13 | N/A | N/A |
| Other Financing Activity | 0 | -39,227 | -17,871 | -17,871 | -17,871 |
| Financing Cash Flow | $1,533 | $606,673 | $280,718 | $279,979 | $276,540 |
| Beginning Cash Position | 92,646 | 45,681 | 45,681 | 45,681 | 45,681 |
| End Cash Position | 55,090 | 92,646 | 27,256 | 25,085 | 69,105 |
| Net Cash Flow | $-37,556 | $46,965 | $-18,425 | $-20,596 | $23,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,406 | -134,679 | -95,497 | -58,612 | -33,830 |
| Capital Expenditure | -187 | -972 | -327 | -89 | N/A |
| Free Cash Flow | -54,593 | -135,651 | -95,824 | -58,701 | -33,830 |